Thursday 27th April

07:30—08:45

Annex Hall 2

World Young Leaders in Dementia (WYLD)
Interdisciplinary perspectives: Young investigators on the road to a holistic approach to dementia prevention and care

WYLD logo

Depathologizing Dementia: A Qualitative Analysis of a Multi-sectoral Working Group
Rebekah Churchyard (Canada)

Care Vs. Cure: De-Pathologizing Dementia through Arts, Creativity and Education
Liza Futerman (Canada)

The Importance of Cognitive Reserve for Promoting Cognitive Health in Aging Populations Worldwide
Francisca S. Then (Germany)
Bilingualism and Alzheimer’s: Neuropsychoanalytical Perspectives
Caitlin Ware (France)
 


Partner in Balance: a blended care intervention for informal caregivers of people with early stage dementia
Marjolein de Vugt

Partner in Balance: a blended care intervention for informal caregivers of people with early stage dementia
Marjolein de Vugt


Thursday 27th April

07:30—08:45

Annex Hall 1

Axovant
The Evolution of Dementia Drug Development: The Role of the Cholinergic System

 Axovant Logo High Res

The Evolution of Dementia Drug Development: The Role of the Cholinergic System
Heii Arai M.D., Ph.D (Japan)

Impact of Cholinergic Deficits in Dementia with Lewy Bodies
Etsuro Mori M.D., Ph.D. (Japan)



Partner in Balance: a blended care intervention for informal caregivers of people with early stage dementia
Marjolein de Vugt

Partner in Balance: a blended care intervention for informal caregivers of people with early stage dementia
Marjolein de Vug

Thursday 27th April

13:00—14:00

Alzheimer Nederland
Ehealth interventions to support informal caregivers of people with dementia

Alzheimer Netherland
Alzheimer Centrum Limburg

DEMENTIE.NL: an online platform for family caregivers of people with dementia; research & practice
Marco Blom (The Netherlands)

RHAPSODY: an online intervention to support caregivers of people with young onset dementia
Joany Millenaar (The Netherlands)

Partner in Balance: a blended care intervention for informal caregivers of people with early stage dementia
Marjolein de Vugt (The Netherlands)


Thursday 27th April

13:00—14:00

Eli Lilly 
Path to 2025: a global conversation on Health Care System readiness

LillyLogo_RGB_Red

Moderator: Marc Wortmann

Drug development in Alzheimer’s disease: the path to   2025 – a Global perspective
Philip Scheltens (The Netherlands)
Japan – preparing to meet the needs of a super ageing society
Dr Kayano (Japan)

Panel discussion, giving the EU/UK and US perspective
Jeremy Hughes and Harry Johns (United States)

 Q/A session moderated by Marc Wortmann with all speakers


Partner in Balance: a blended care intervention for informal caregivers of people with early stage dementia
Marjolein de Vugt

Partner in Balance: a blended care intervention for informal caregivers of people with early stage dementia
Marjolein de Vugt

Thursday 27th April

17:45—18:45

PROMOTE
Building capacity of psychosocial research to advance the health and wellbeing of persons with dementia in the Asia-Pacific region

Chairs: Henry Brodaty and Yun-Hee Jeon

 

Established in 2013, Psychosocial Research Consortium to Advance Mental Health of Older People in the Asia Pacific Region (PROMOTE) is the first consortium of researchers from the Asia-Pacific region dedicated to psychosocial research to improve mental health of older people. The purpose of this workshop is twofold: i) to enhance capacity of and collaboration between psychosocial researchers in the region; and ii) to identify and determine key research issues that are important and feasible to member countries in promoting psychosocial care of people living with dementia. At the ADI Asia-Pacific Regional meeting in November 2016, three research projects were proposed: (a) an observational study of dyads to determine the time and pathways to diagnosis and the services received over 12 months; (b) a qualitative research to examine commonalities and uniqueness of experiences of people with dementia and their carers; and (c) a narrative review of research evidence on psychosocial research in dementia in the region. In this workshop we will discuss ways through which the next collaborative research projects can be carried out in this region. Those interested in participating in psychosocial research in Asia-Pacific region are strongly encouraged to attend.

Thursday 27th April

17:45—18:45

Biomed Central

Publishing your research: what do Editors look for?

BMC_logo_main_gloss  

Philip Scheltens, Editor-in-Chief, Alzheimer’s Research & Therapy

Representative, BioMed Central 

Thursday 27th April

17:45—18:45

Otsuka & ADI

 OAPI_Logo_Color_Left_1Line

Disrupting Alzheimer’s: Global Opportunities for Technology

Goal: To present ideas and solicit discussion in a global context on opportunities for technology to create solutions for people with Alzheimer’s and related dementias and their care partners.

Friday 28th April

07:30—08:30

Global Dementia Policy

An overview of where we are with the latest dementia policies

Chair: Marc Wortmann

WHO Global Action Plan on the Public Health Response to Dementia
Tarun Dua (World Health Organization)

Update on the work of the World Dementia Council
Yves Joanette, Chair, World Dementia Council

Index of readiness for innovation - a joint project of ADI and the Global Coalition
Michael Hodin, Global Coalition on Ageing


Friday 28th April

07:30—08:30

Biogen

The Emerging Picture of Alzheimer’s Disease: Navigating the Challenges of Early Diagnosis and the Patient Journey

Biogen_Logo_Standard-cmyk-01

Patient Case Study Part 1: Meet the Patient

Phillip Scheltens (The Netherlands)

Being Mindful of Thinking, Memories, and Conversation

John Harrison (United Kingdom)

Patient Case Study Part 2: Getting Timely and Thorough Assessments

Phillip Scheltens (The Netherlands)

Detecting Changes Inside the Body – Brain Scans and Biomarkers

Hitoshi Shimada (Japan)

Patient Case Study Part 3: Receiving a Diagnosis

Phillip Scheltens (The Netherlands)

Living with Alzheimer’s Disease – Conversations and Care Plans

Rafael Blesa (Spain)

Summary and Close

Phillip Scheltens (The Netherlands)



Friday 28th April

12:45—13:45

Eisai

Creating Society that Lives Well with Dementia

 Chair Dr. Akira Homma
Dr. Kiyoshi Maeda
CorporateLogomark

Perspectives and Outcomes of the National policy for Dementia
Dr. Masahiro Shigeta (Japan)           

Enriching Social Capitals for Dementia in Japan
Dr. Shuichi Awata (Japan)

Encouraging Human Resources for Dementia in Japan
Dr. Heii Arai (Japan)


Friday 28th April

 

12:45—13:45

Nestlé Japan

Skin Health: A New Frontier to Improve Quality, Costs, and Care for Older Adults with Dementia

 Chair Dr. Michael Hodin (CEO, Global Coalition on Aging)
 New_2015_Black_NoR_H[1]

Introduction: Pruritus in the Elderly 
Dr.Toshiya Ebata

Presentation of Study Findings from Two Studies
Dr. Akihiko Ikoma
Demonstration of TBA New Wearable Technology
Dr. Toshiya Ebata
Dr. Akihiko Ikoma
Panel Discussion
Moderator: Michael Hodin
Skin Health as an Avenue for Improved Care in Dementia
Akihiko Ikoma (Japan)
Toshiya Ebata (Japan)
Hao Luo (China)
Marc Wortmann (United Kingdom)
   In this session, researchers with SHIELD, Nestlé Skin Health’s global innovation initiative to advance the future of skin health, will share the results from a series of exciting new studies on skin health and itch. Together, these studies represent a radical rethinking of care for all older adults and have particularly exciting implications for the care and treatment of older adults with dementia. During the session, the researchers will introduce and demo the new wearable app that is enabling much of this research. 







Friday 28th April

17:45—18:45

Clinical Art Association in Kyoto

Clinical art therapy as a strategy for the prevention of dementia

 Chair Prof. Masanori NAKAGAWA (Japan)
 CAA Clinical Art and dementia
Toshiki MIZUNO, MD, PhD.  (Japan)
Usefulness of clinical art for dementia
Kazuo HACHIYA  (Japan)
The program for prevention of dementia in Kyoto
Mieko FURUI  (Japan)              
 Care with Clinical Art
Midori IWAMOTO  (Japan)


Friday 28th April

17:45—18:45

TauRx

Targeting Tau Tangles to Treat Alzheimer’s

TauRx logo new - blue with light blue

Tau pathology in Alzheimer’s disease and the potential of tau aggregation inhibition
Prof. Claude Wischik, Professor of Psychiatric Gerontology, University of Aberdeen and Executive Chairman, TauRx Pharmaceuticals Ltd.

Results from two Phase 3 studies of LMTX, a novel tau aggregation inhibitor, in mild to moderate Alzheimer’s disease
Dr. Serge Gauthier, Director, McGill University Research Centre for Studies in Aging

Questions and discussion


Saturday 29th April

07:30—08:30

ADI briefings for Alzheimer associations

 

These briefings are targeted to ADI member associations, but everyone is welcome!

Chair: Glenn Rees

World Alzheimer’s Month 2017

Dale Goldhawk (ADI Vice Chair) and James Smith (ADI Communications Officer) will give an overview of the plans and messages for World Alzheimer’s Month 2017

Followed by Q and A

 

The Human Rights Agenda

Nicole Batsch, consultant at ADI, will introduce a brief and tools for working with the Convention on the Rights of People with Disabilities (CRPD) to the benefit of those living with dementia. This work is prepared in close collaboration with Dementia Alliance International

Followed by Q and A 

Saturday 29th April

12:45—13:45

NCD Alliance

2_NCDA CMYK

Strengthening Health Systems for Dementia and NCD (non-communicable diseases) Co-morbidities: Successful Approaches for Integrated Care

 

Living with dementia and other NCDs poses challenges ranging from financial costs of care to treatment adherence. In order to respond effectively to NCD co-morbidities, there is a need to strengthen and reorient health systems for chronic conditions, adopt a truly holistic and person-centred approach, and to integrate care packages across dementia and other NCDs. Interventions must be made at the levels of surveillance, health system planning, workforce training, clinical guidelines, and quality monitoring.

Goal: To recognise the links between dementia and other NCDs, understand the challenge of living with multiple NCDs, and identify policies and interventions which have strengthened health systems for chronic care NCDs 


Saturday 29th April

12:45—13:45

Nestlé Japan
Evidence-Based Cognitive Training: BrainHQ
Chair:  Dr. Takashi Asada (Japan)
Speaker:  Dr. Michael Merzenich (United States)
 New_2015_Black_NoR_H[1] Sponsored by Nestlé Japan, this lunchtime session will introduce BrainHQ, an evidence-based cognitive training program. Dr. Michael Merzenich, the program’s developer, will discuss the program’s numerous cognitive benefits, which include improved brain speed, improved memory, reduced auto-crash rate, reduced depression, and reduced risk of dementia. These and other benefits of BrainHQ have been validated in over 70 peer-reviewed studies. The group version of the program, which is led by an instructor, will soon be introduced in Japan.




Programme subject to change.